The objective of this study was to delineate an efficient and effective diagnostic approach in evaluating a patient with weight loss and a posterior mediastinal mass. This case demonstrates the evaluation and management of a 22-year-old Army private with weight loss, chest pain, and a posterior mediastinal mass on chest X-ray. The importance of obtaining a thorough travel history to formulate the differential diagnosis is highlighted.
A 22-year-old active duty Army private, complaining of persistent chest and back pain for 1 month, presented to the Emergency Room at Womack Army Medical Center in Fort Bragg, Fayetteville, North Carolina. He noted a 20-kg weight loss over 1 year and a right upper lip lesion for 1 month (Fig. 1) . He had no significant past medical history and took only ibuprofen as needed for pain. The patient drank alcohol occasionally and smoked one pack of cigarettes every 3 days. His family history was noncontributory. He was raised in the southeastern United States and had remained in the Southeast except for a 2-year tour of duty to Fort Irwin, California before transfer to Fort Bragg, North Carolina. Upon presentation, his vital signs were normal. A 1-cm erythematous papule was present over his right upper lip. The remainder of his physical examination was normal. The white blood cell count was 9.7 K/L (4.4-11.0 K/L), hemoglobin 9.9 g/dL (13.0-17.2 g/dL), platelet count 440 K/L (142-424 K/L), and serum chemistries were normal. Posteroanterior and lateral chest X-ray showed bilateral reticulonodular infiltrates and a midline posterior mediastinal mass. Computed tomography of the chest showed a miliary type interstitial pattern of both lower lobes with pleural thickening. A paraspinous soft tissue mass was noted at the T3-T7 level. The patient was placed in respiratory isolation. An examination of three sputum samples for acid-fast bacilli was negative. Gummas of tertiary syphilis are granulomatous lesions that typically involve the skin, upper respiratory tract, liver, and stomach, but any organ can be involved. The lesions can range from microscopic to several centimeters in size and from benign to destructive in nature. This patient's paraspinal soft tissue and skin lesions could have been consistent with tertiary syphilis, but his pulmonary parenchymal involvement was inconsistent with this diagnosis. Additionally, late syphilis usually occurs 10 to 30 years after primary infection in untreated patients, making this diagnosis unlikely.
Based on the presentation and the above findings
Osteosarcoma is a destructive malignancy of bone usually occurring in the first 3 decades of life. It most commonly involves the long bones and can metastasize to the lungs. Pain and swelling are the usual presenting symptoms. This patient's chest X-ray findings were not consistent with metastases, and his computed tomography scan showed a paraspinous mass not a bony mass.
Histoplasmosis is caused by the fungus Histoplasma capsulatum, endemic to the central United States (Ohio River Valley). Most infections are self-limited, but acute pulmonary or disseminated infections can occur. Chronic pulmonary disease most commonly presents over several months with weight loss, cough, and night sweats. Disseminated disease can lead to pancytopenia from bone marrow involvement, adenopathy, and hepatosplenomegaly. Chest X-ray shows a miliary pattern (commonly mistaken for tuberculosis) or nodules. This patient's computed tomography findings could have been consistent with histoplasmosis, but the presence of the soft tissue mass and the patient's geographic location made the illness less likely.
Coccidioidomycosis is caused by the fungus Coccidioides immitis, endemic to the southwestern United States and Central and South America. Like histoplasmosis, this infection can range from asymptomatic to severe disseminated disease. Symptomatic disease occurs in approximately 40% of patients and can be characterized as primary acute disease, disseminated disease, and pulmonary disease.
1 Pulmonary disease is characterized by fever and cough along with chest pain, malaise, and rash. Chest X-ray can show hilar adenopathy, pleural/ pericardial effusions, and infiltrates. Disseminated disease occurs late and is characterized by weight loss, cough, and fevers. Sites of dissemination include skin, bone, soft tissue, and the central nervous system. Other signs and symptoms of dissemination depend upon the site involved. This patient was from a nonendemic area for C. immitis. However, his deployment to an endemic area was an obvious risk factor especially because he was at a training site where exposure to airborne organisms from soil disruption (through digging of fighting positions, heavy vehicle traffic, etc.) was likely. This patient's history of travel to an endemic area and features consistent with disseminated coccidioidomycosis made it a likely diagnosis.
Tuberculosis is caused by Mycobacterium tuberculosis. Tuberculosis can present as either primary or secondary pulmonary disease or with extrapulmonary symptoms. Worldwide, primary pulmonary tuberculosis often occurs in children, involves the middle and lower lobes, and is associated with hilar adenopathy. Secondary tuberculosis occurs with reactivation of the bacteria, manifested as cough, fevers, night sweats, and weight loss. The apices of the lungs are usually involved. Extrapulmonary tuberculosis can affect almost every organ system, most commonly the lymph nodes, genitourinary system, musculoskeletal system, and central nervous system. Signs and symptoms of extrapulmonary tuberculosis depend on the system involved. Tuberculosis could have explained this patient's presentation. However, given his extensive pulmonary involvement and serial negative acid-fast bacilli stains, it was less likely.
Based on the computed tomography scan, the patient was referred for computed tomography-guided biopsy that showed granulomatous tissue containing numerous fungi consistent with C. immitis. Lip biopsy also showed fungi consistent with C. immitis. Cultures from both samples eventually grew C. immitis. 
Regarding this patient's disease

E2 rank puts him at increased risk for hospitalization
This patient had disseminated coccidioidomycosis defined by spread of disease beyond pulmonary parenchyma or hilar nodes. There are various risk factors for disseminated coccidioidomycosis including African-American race, low socioeconomic status, and pregnancy. 2 African-American descent is associated with a 4.6 times increased risk for disseminated, severe disease possibly due to differences in major histocompatability genes that play a role in cell-mediated immunity. 2 The most important risk factor for disseminated disease is defective cellmediated immunity, as seen in patients with HIV, those on higher doses of corticosteroids (more than 20 mg/day prednisone), or transplant recipients. Alcohol use and a history of cigarette smoking do not convey increased risk for disseminated coccidioidomycosis. 2 In a case series of Navy personnel, junior pay grades (E1-E6) had higher hospitalization rates for coccidioidomycosis than higher pay grades. It is unclear whether the higher hospitalization rates represented increased exposure from daily duties performed by junior personnel or were a result of efforts to isolate infected personnel from their barracks. In patients with disseminated coccidioidomycosis, there are several important tests to perform. As C. immitis has a predilection to disseminate to the central nervous system, a lumbar puncture must be performed. Routine cerebrospinal fluid laboratories such as protein, glucose, and cell count should be sent as well as fungal culture. If lumbar puncture results show C. immitis involvement, therapy will differ.
The ESR is a nonspecific test that indirectly measures inflammation. Acute phase reactants (especially fibrinogen) rise in response to any acute inflammatory stimulus. Higher levels of fibrinogen in the blood cause erythrocyte clumping and a rise in ESR. 4 Disseminated coccidioidomycosis causes a rise in acute phase reactants and ESR. 5 As the infection is effectively treated, the ESR will correspondingly decrease. Therefore, serial ESR measurements can be a good, albeit nonspecific, way to monitor response to therapy.
The Meridian Premier Coccidioides enzyme immunoassay otherwise known as MPC-EIA is a recently developed enzymelinked immunosorbent assay that qualitatively detects both IgM and IgG antibodies to C. immitis antigens. It can be used on both serum and cerebrospinal fluid specimens. Favorable test characteristics and a rapid turnaround time make it an excellent screening and confirmatory test for coccidioidomycosis. A limitation of this method is that it cannot be used for serial titer measurements. 6 CF is an indirect way of quantitatively measuring serum IgG antibody against C. immitis. The CF antibody is useful for both diagnosing acute disease and for following disease course. A positive CF at any titer level is a good indication of an active infection when confirmed with an IgM test. A CF titer above 1:16 indicates the possibility of disseminated disease, and levels above 1:128 virtually confirm dissemination. 1 After initial diagnosis and initiation of treatment, CF levels can be followed serially, with fourfold changes in titers indicating either progres- 
. Lipid-associated amphotericin, 3-5 mg/kg day
There are various treatment modalities available for C. immitis infection. For many years, amphotericin B was the only effective antifungal agent with activity against C. immitis. Currently, amphotericin B is used primarily in patients with progressive disease, those with lesions near vital organs, or in pregnant patients (because triazoles are teratogenic 8 ). Because this patient had a lesion near his vertebral column, amphotericin was the correct therapeutic choice. Both itraconazole and fluconazole are Food and Drug Administration approved for the treatment of disseminated coccidioidomycosis. A comparative study of these agents showed a 57% response rate on fluconazole versus a 72% response rate on itraconazole at 12 months. This difference was not statistically significant and was believed to result from a lower dose of fluconazole being used (400 mg/day versus 800 mg/day). 9 Intrathecal amphotericin B can be used to treat coccidioidomycosis with central nervous system involvement. The dose and duration of therapy have not been established. This patient had no evidence of central nervous system involvement, thus intrathecal amphotericin was not indicated. Lipid-associated amphotericin formulations are newer formulations of amphotericin. They utilize a lipid drug delivery system that decreases infusion-related toxicities including nephrotoxicity. There have been no clinical trials comparing amphotericin B to liposomal amphotericin for coccidioidomycosis in humans. However, a study in mice showed that the two agents were both significantly and uniformly effective when given intravenously to treat C. immitis infections. 10 Based upon this, it has been extrapolated that liposomal amphotericin can be used in the treatment of coccidioidomycosis.
The patient was started on amphotericin B deoxycholate (1 mg/kg day) and observed. Magnetic resonance imaging showed the paraspinous mass to be more extensive than shown on the computed tomography scan, including T3-T6 bony involvement (Fig. 2 ). An orthopedics consult was obtained. Over the following 4 days, the patient's serum creatinine increased from 1.0 to 2.2 mg/dL (0.6-1.3 mg/dL). It is well known that amphotericin can cause acute renal failure from acute tubular necrosis. However, other renal effects can occur even earlier. Amphotericin binds to cholesterol in cell membranes, leading to pore formation and changes in cell membrane permeability. When nephron tubule cells are affected, shifts of various electrolytes occur as the membrane defects allow electrolytes to flow down their concentration gradients. Potassium secretion is increased in the distal tubule, leading to hypokalemia. Hydrogen secretion is decreased, causing retention of chloride and hyperchloremia (with acidosis).
All of the following electrolyte abnormalities have been as
11 Although much less common, hyperkalemia has also been reported, an effect attributed to immediate membrane permeability changes causing efflux of intracellular potassium into the serum. 11 Amphotericin has also been shown to cause hypomagnesemia, possibly from altered magnesium distribution from disordered cellular membrane permeability. 11 There is no association between amphotericin toxicity and hypermagnesemia. Unfortunately, although volume repletion may help slow or prevent acute tubular necrosis, it has no effect on membrane permeability and the resulting electrolyte abnormalities. 12 Large amounts of both potassium and magnesium supplements may be needed in patients on amphotericin. It must be remembered that hypokalemia will not be corrected by repletion unless the magnesium deficit is also corrected. Because of worsening nephrotoxicity, the patient's therapy was changed to fluconazole (800 mg/day). Unfortunately, his condition failed to improve, eventually demonstrating signs of spinal cord impingement. The patient's therapy was changed to liposomal amphotericin (Ambisome, 5 mg/kg day) and he underwent removal of the T3-T6 vertebrae. After continuing liposomal amphotericin for 4 weeks postoperatively, the patient was transitioned to oral fluconazole (400 mg/day) and was discharged with a plan for lifelong therapy.
Coccidioidomycosis continues to be prevalent in the United
States with approximately 100,000 cases per year. Of these, an estimated 1% are disseminated. 8 Military physicians in particular must be vigilant for this disease, as there are large numbers of personnel stationed in the desert southwest and even more who pass through while training at the National Training Center at Fort Irwin, California. These personnel engage in activities and maneuvers that make them more susceptible to coccidioidomycosis. The military is an ethnically diverse institution, and non-Caucasian soldiers are at increased risk of disease when traveling to C. immitis endemic areas. Physicians should recognize that patients may present with signs of C. immitis infection when they are thousands of miles from the endemic area, so a thorough travel history and a high index of suspicion are of paramount importance. Recognition of the infection is important because earlier detection and treatment can prevent progression to disseminated disease and destructive complications. There are no effective means of precautions; attempts at developing a vaccine have been unsuccessful to date.
Disseminated coccidioidomycosis is a chronic disease. With triazole therapy, 18% to 28% of patients can relapse even if they initially responded to therapy. 9 Prediction of relapse is difficult but is associated with peak CF titers greater than or equal to 1:256 or persistent anergy to coccidioidin skin testing. 7 The patient described in this case had severe disseminated disease and a CF titer of 1:256. Thus, he is currently on lifelong triazole therapy.
